|4Mar 6, 4:05 PM ET

Emany Sravan Kumar 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 6, 2024

Insider Transaction Report

Form 4
Period: 2024-03-04
Emany Sravan Kumar
SVP, Chief Financial Officer
Transactions
  • Purchase

    Class A Common Stock

    2024-03-04$9.38/sh+10,684$100,216301,733 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.37 to $9.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4